Trial intelligence / Profile preview

Neoadjuvant Chemotherapy in Localized Neuroblastoma Without MYCN Amplification

NCT00025428Phase 3Completed

Sponsor
SIOP
Start
Dec 2000
Modality
DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
Countries
12
01

Overview

A Phase 3 trial of carboplatin, etoposide, cyclophosphamide, doxorubicin, vincristine in neuroblastoma, sponsored by SIOP. Started Dec 2000; status: completed.

02

Drugs

carboplatinetoposidecyclophosphamidedoxorubicinvincristine
03

Conditions

neuroblastoma

Beyond the preview

Go deeper on NCT00025428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00025428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call